To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

July 21, 2022

Dr. Nader Sanai Discusses The Newest Advances In Treating GBM

On May 19th, 2022, The End Brain Cancer Initiative held our GBM "Know All Your Treatment Options" Educational, Advocacy & Outreach event. We had some amazing speakers and among them was Dr. Nader Sanai, Chief Scientific Officer/Director at the Ivy Brain Tumor Center at the Barrow Neurological Institute. Dr. Sanai shared some incredibly valuable information that we would like to share with you in case you missed it!

Dr. Sinai seminar quad chart

Meet Dr. Nader Sanai the J.N. Harber Professor of Neurological Surgery and also holds the Francis & Dionne Najafi Chair in Neurosurgical Oncology at Barrow Neurological Institute. As an internationally recognized brain tumor surgeon, his specialty clinical practice is devoted entirely to patients with benign and malignant brain tumors, particularly those in high-risk areas. He is a world expert in using brain mapping techniques to identify and preserve areas of motor, sensory, and language function during surgery. As one of the nation’s highest volume neurosurgical oncologists, Dr. Sanai was elected, in 2016, as the youngest member of the American Academy of Neurological Surgeons, the most respected academic organization in neurosurgery.

Treatment options logo

If you missed our full "Know All Your Treatment Options" event on May 19th, we have linked the entire video below.

Supporter logos


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram